Connection

HANUMANTHA PULIVARTHI to Humans

This is a "connection" page, showing publications HANUMANTHA PULIVARTHI has written about Humans.
Connection Strength

0.401
  1. Separase loss of function cooperates with the loss of p53 in the initiation and progression of T- and B-cell lymphoma, leukemia and aneuploidy in mice. PLoS One. 2011; 6(7):e22167.
    View in: PubMed
    Score: 0.010
  2. A handcuff model for the cohesin complex. J Cell Biol. 2008 Dec 15; 183(6):1019-31.
    View in: PubMed
    Score: 0.008
  3. Generation of an induced pluripotent stem cell line from an individual with a heterozygous RECQL4 mutation. Stem Cell Res. 2018 12; 33:36-40.
    View in: PubMed
    Score: 0.008
  4. Overexpression of Separase induces aneuploidy and mammary tumorigenesis. Proc Natl Acad Sci U S A. 2008 Sep 02; 105(35):13033-8.
    View in: PubMed
    Score: 0.008
  5. Establishment of a human embryonic stem cell line with homozygous TP53 R248W mutant by TALEN mediated gene editing. Stem Cell Res. 2018 05; 29:215-219.
    View in: PubMed
    Score: 0.008
  6. A homozygous p53 R282W mutant human embryonic stem cell line generated using TALEN-mediated precise gene editing. Stem Cell Res. 2018 03; 27:131-135.
    View in: PubMed
    Score: 0.008
  7. Novel t(1;3)(q21,p21) translocation in a basal cell adenocarcinoma of the parotid gland: potential association with tumorigenesis. Hum Pathol. 2016 08; 54:189-92.
    View in: PubMed
    Score: 0.007
  8. Translocation t(7;12) as the sole chromosomal abnormality resulting in ACTB-GLI1 fusion in pediatric gastric pericytoma. Hum Pathol. 2016 07; 53:137-41.
    View in: PubMed
    Score: 0.007
  9. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations. Clin Cancer Res. 2016 Feb 01; 22(3):725-33.
    View in: PubMed
    Score: 0.007
  10. Comparative genomic hybridization for analysis of changes in DNA copy number in multiple myeloma. Methods Mol Med. 2005; 113:71-83.
    View in: PubMed
    Score: 0.006
  11. Cytogenetic landscape of paired neurospheres and traditional monolayer cultures in pediatric malignant brain tumors. Neuro Oncol. 2015 Jul; 17(7):965-77.
    View in: PubMed
    Score: 0.006
  12. Notch activation as a driver of osteogenic sarcoma. Cancer Cell. 2014 Sep 08; 26(3):390-401.
    View in: PubMed
    Score: 0.006
  13. Molecular cytogenetic characterization of mammary neuroendocrine carcinoma. Hum Pathol. 2014 Sep; 45(9):1951-6.
    View in: PubMed
    Score: 0.006
  14. Amplification and over-expression of MAP3K3 gene in human breast cancer promotes formation and survival of breast cancer cells. J Pathol. 2014 Jan; 232(1):75-86.
    View in: PubMed
    Score: 0.006
  15. Contribution of an alveolar cell of origin to the high-grade malignant phenotype of pregnancy-associated breast cancer. Oncogene. 2014 Dec 11; 33(50):5729-39.
    View in: PubMed
    Score: 0.006
  16. Telomere stability correlates with longevity of human beings exposed to ionizing radiations. Oncol Rep. 2003 Nov-Dec; 10(6):1733-6.
    View in: PubMed
    Score: 0.006
  17. Integrated multimodal genetic testing of Ewing sarcoma--a single-institution experience. Hum Pathol. 2013 Oct; 44(10):2010-9.
    View in: PubMed
    Score: 0.005
  18. Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance. Am J Pathol. 2013 Jun; 182(6):2048-57.
    View in: PubMed
    Score: 0.005
  19. Sleeping beauty system to redirect T-cell specificity for human applications. J Immunother. 2013 Feb; 36(2):112-23.
    View in: PubMed
    Score: 0.005
  20. Frequent detection of CBFA2T3::GLIS2 fusion and RAM-phenotype in pediatric non-Down syndrome acute megakaryoblastic leukemia: a possible novel relationship with aberrant cytoplasmic CD3 expression. Leuk Lymphoma. 2023 02; 64(2):462-467.
    View in: PubMed
    Score: 0.005
  21. LncRNA PVT-1 promotes osteosarcoma cancer stem-like properties through direct interaction with TRIM28 and TSC2 ubiquitination. Oncogene. 2022 Dec; 41(50):5373-5384.
    View in: PubMed
    Score: 0.005
  22. A systems biology approach reveals common metastatic pathways in osteosarcoma. BMC Syst Biol. 2012 May 28; 6:50.
    View in: PubMed
    Score: 0.005
  23. Near-Haploid B-Cell Acute Lymphoblastic Leukemia in a Patient with Rubinstein-Taybi Syndrome. Pediatr Hematol Oncol. 2022 Nov; 39(8):747-754.
    View in: PubMed
    Score: 0.005
  24. Similar patterns of genomic alterations characterize primary mediastinal large-B-cell lymphoma and diffuse large-B-cell lymphoma. Genes Chromosomes Cancer. 2002 Feb; 33(2):114-22.
    View in: PubMed
    Score: 0.005
  25. t(3;8) as the sole chromosomal abnormality in a myoepithelial carcinoma ex pleomorphic adenoma: a putative progression event. Head Neck. 2013 Jun; 35(6):E181-3.
    View in: PubMed
    Score: 0.005
  26. Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome. Clin Cancer Res. 2011 Nov 15; 17(22):7003-14.
    View in: PubMed
    Score: 0.005
  27. De novo B lymphoblastic leukemia/lymphoma in an adult with t(14;18)(q32;q21) and c-MYC gene rearrangement involving 10p13. Leuk Lymphoma. 2011 Nov; 52(11):2195-9.
    View in: PubMed
    Score: 0.005
  28. Cell type-dependent biomarker expression in adenoid cystic carcinoma: biologic and therapeutic implications. Cancer. 2010 Dec 15; 116(24):5749-56.
    View in: PubMed
    Score: 0.005
  29. Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance. Clin Cancer Res. 2010 Oct 01; 16(19):4722-31.
    View in: PubMed
    Score: 0.005
  30. Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma. Oncogene. 2010 Sep 02; 29(35):4938-46.
    View in: PubMed
    Score: 0.004
  31. piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies. Hum Gene Ther. 2010 Apr; 21(4):427-37.
    View in: PubMed
    Score: 0.004
  32. Genomic profiling of plasmablastic lymphoma using array comparative genomic hybridization (aCGH): revealing significant overlapping genomic lesions with diffuse large B-cell lymphoma. J Hematol Oncol. 2009 Nov 12; 2:47.
    View in: PubMed
    Score: 0.004
  33. Pediatric myeloid sarcoma: a single institution clinicopathologic and molecular analysis. Pediatr Hematol Oncol. 2020 Feb; 37(1):76-89.
    View in: PubMed
    Score: 0.004
  34. Genetically transforming human mesenchymal stem cells to sarcomas: changes in cellular phenotype and multilineage differentiation potential. Cancer. 2009 Oct 15; 115(20):4795-806.
    View in: PubMed
    Score: 0.004
  35. Translocation (4;15)(p16;q24): a novel reciprocal translocation in a patient with BCR/ABL negative myeloproliferative syndrome progressing to blastic phase. Cancer Genet Cytogenet. 1999 May; 111(1):18-20.
    View in: PubMed
    Score: 0.004
  36. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1. Anticancer Res. 2009 Apr; 29(4):1255-62.
    View in: PubMed
    Score: 0.004
  37. Molecular cloning and chromosomal localization of Chinese hamster telomeric protein chTRF1. Its potential role in chromosomal instability. Oncogene. 1998 Oct 22; 17(16):2137-42.
    View in: PubMed
    Score: 0.004
  38. Deletion of 1p32-p36 is the most frequent genetic change and poor prognostic marker in adenoid cystic carcinoma of the salivary glands. Clin Cancer Res. 2008 Aug 15; 14(16):5181-7.
    View in: PubMed
    Score: 0.004
  39. Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract. Cancer Res. 1998 Jul 01; 58(13):2727-32.
    View in: PubMed
    Score: 0.004
  40. Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas. J Clin Endocrinol Metab. 1998 May; 83(5):1766-70.
    View in: PubMed
    Score: 0.004
  41. Juvenile juxtacortical chondromyxoid fibroma of bone: a case report. Hum Pathol. 2008 Jun; 39(6):960-5.
    View in: PubMed
    Score: 0.004
  42. Translocation t(6;14) as the sole chromosomal abnormality in adenoid cystic carcinoma of the base of tongue. Head Neck Pathol. 2007 Dec; 1(2):165-8.
    View in: PubMed
    Score: 0.004
  43. Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D. J Neurooncol. 2008 Feb; 86(3):245-56.
    View in: PubMed
    Score: 0.004
  44. Genetic abnormalities associated with chemoradiation resistance of head and neck squamous cell carcinoma. Clin Cancer Res. 2007 Aug 01; 13(15 Pt 1):4386-91.
    View in: PubMed
    Score: 0.004
  45. Establishment and genomic characterization of primary salivary duct carcinoma cell line. Oral Oncol. 2017 06; 69:108-114.
    View in: PubMed
    Score: 0.004
  46. Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative subsets and histologic progression. Cytogenet Genome Res. 2007; 118(2-4):337-44.
    View in: PubMed
    Score: 0.004
  47. Molecular cytogenetic applications in analysis of the cancer genome. Methods Mol Biol. 2007; 383:165-85.
    View in: PubMed
    Score: 0.004
  48. TP53 loss creates therapeutic vulnerability in?colorectal cancer. Nature. 2015 Apr 30; 520(7549):697-701.
    View in: PubMed
    Score: 0.003
  49. The p73 locus is commonly deleted in non-Hodgkin's lymphomas. Leuk Res. 2004 Dec; 28(12):1341-5.
    View in: PubMed
    Score: 0.003
  50. Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform. Cancer Genet Cytogenet. 2004 Dec; 155(2):97-107.
    View in: PubMed
    Score: 0.003
  51. Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications. Clin Cancer Res. 2014 Dec 15; 20(24):6570-81.
    View in: PubMed
    Score: 0.003
  52. Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung. Clin Cancer Res. 2004 Sep 01; 10(17):5792-803.
    View in: PubMed
    Score: 0.003
  53. Insulin-like growth factor 1 receptor and response to anti-IGF1R antibody therapy in osteosarcoma. PLoS One. 2014; 9(8):e106249.
    View in: PubMed
    Score: 0.003
  54. Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity. Genes Chromosomes Cancer. 2004 Aug; 40(4):355-64.
    View in: PubMed
    Score: 0.003
  55. i(5p) and del(6q) are nonrandom abnormalities in carcinoma cervix uteri. Cytogenetics of two newly developed cell lines. Cancer Genet Cytogenet. 1994 Aug; 76(1):56-8.
    View in: PubMed
    Score: 0.003
  56. Development and characterization of salivary adenoid cystic carcinoma cell line. Oral Oncol. 2014 Oct; 50(10):991-9.
    View in: PubMed
    Score: 0.003
  57. Amplification of MGC2177, PLAG1, PSMC6P, and LYN in a malignant mixed tumor of salivary gland detected by cDNA microarray with tyramide signal amplification. Cancer Genet Cytogenet. 2004 Jul 15; 152(2):124-8.
    View in: PubMed
    Score: 0.003
  58. Overexpression of E2F-1 in lung and liver metastases of human colon cancer is associated with gene amplification. Cancer Biol Ther. 2004 Apr; 3(4):395-9.
    View in: PubMed
    Score: 0.003
  59. Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma. BMC Cancer. 2004 Feb 06; 4:5.
    View in: PubMed
    Score: 0.003
  60. Spatial quantitation of FISH signals in diploid versus aneuploid nuclei. Cytometry A. 2014 Apr; 85(4):339-52.
    View in: PubMed
    Score: 0.003
  61. The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability. Proc Natl Acad Sci U S A. 2003 Sep 30; 100(20):11547-52.
    View in: PubMed
    Score: 0.003
  62. Comprehensive molecular cytogenetic characterization of cervical cancer cell lines. Genes Chromosomes Cancer. 2003 Mar; 36(3):233-41.
    View in: PubMed
    Score: 0.003
  63. Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma. Mol Carcinog. 2003 Feb; 36(2):53-9.
    View in: PubMed
    Score: 0.003
  64. The utility of spectral karyotyping in the cytogenetic analysis of newly diagnosed pediatric acute lymphoblastic leukemia. Leukemia. 2002 Nov; 16(11):2222-7.
    View in: PubMed
    Score: 0.003
  65. Genomic and expression analysis of the 12p11-p12 amplicon using EST arrays identifies two novel amplified and overexpressed genes. Cancer Res. 2002 Nov 01; 62(21):6218-23.
    View in: PubMed
    Score: 0.003
  66. Relationship of XIST expression and responses of ovarian cancer to chemotherapy. Mol Cancer Ther. 2002 Aug; 1(10):769-76.
    View in: PubMed
    Score: 0.003
  67. Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma. Cancer Res. 2002 Jul 15; 62(14):4089-94.
    View in: PubMed
    Score: 0.003
  68. p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas. Genes Dev. 2002 Apr 15; 16(8):984-93.
    View in: PubMed
    Score: 0.003
  69. Coexistence of independent myelodysplastic and Philadelphia chromosome positive clones in a patient treated with hydroxyurea. Leuk Res. 2002 Apr; 26(4):417-20.
    View in: PubMed
    Score: 0.003
  70. Spectral karyotyping identifies new rearrangements, translocations, and clinical associations in diffuse large B-cell lymphoma. Blood. 2002 Apr 01; 99(7):2554-61.
    View in: PubMed
    Score: 0.003
  71. Multicolor spectral karyotyping of serous ovarian adenocarcinoma. Genes Chromosomes Cancer. 2002 Feb; 33(2):123-32.
    View in: PubMed
    Score: 0.003
  72. Spectral karyotyping analysis of head and neck squamous cell carcinoma. Laryngoscope. 2001 Sep; 111(9):1545-50.
    View in: PubMed
    Score: 0.002
  73. Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification. Cancer Res. 2001 Jun 01; 61(11):4506-13.
    View in: PubMed
    Score: 0.002
  74. Multicolor spectral karyotyping identifies novel translocations in childhood acute lymphoblastic leukemia. Leukemia. 2001 Mar; 15(3):468-72.
    View in: PubMed
    Score: 0.002
  75. Trisomy 1q, 2, and 20 in a case of hepatoblastoma: possible significance of 2q35-q37 and 1q12-q21 rearrangements. Cancer Genet Cytogenet. 2000 Dec; 123(2):140-3.
    View in: PubMed
    Score: 0.002
  76. An apparent interlocus gene conversion-like event at a putative tumor suppressor gene locus on human chromosome 6q27 in a Burkitt's lymphoma cell line. DNA Res. 2000 Aug 31; 7(4):261-72.
    View in: PubMed
    Score: 0.002
  77. Improving degenerate oligonucleotide primed PCR-comparative genomic hybridization for analysis of DNA copy number changes in tumors. Genes Chromosomes Cancer. 2000 Aug; 28(4):395-403.
    View in: PubMed
    Score: 0.002
  78. Genome-wide screening for radiation response factors in head and neck cancer. Laryngoscope. 2000 Aug; 110(8):1251-6.
    View in: PubMed
    Score: 0.002
  79. Genetic analysis of the APAF1 gene in male germ cell tumors. Genes Chromosomes Cancer. 2000 Jul; 28(3):258-68.
    View in: PubMed
    Score: 0.002
  80. A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo. Neuro Oncol. 2010 Jun; 12(6):580-94.
    View in: PubMed
    Score: 0.002
  81. Comparative genomic hybridization study of de novo myeloid neoplasia. Acta Haematol. 2000; 104(1):25-30.
    View in: PubMed
    Score: 0.002
  82. Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphoma with t(9;14)(p13;q32). Leuk Lymphoma. 1999 Jun; 34(1-2):25-33.
    View in: PubMed
    Score: 0.002
  83. Chromosome 18 breakpoint in t(11;18)(q21;q21) translocation associated with MALT lymphoma is proximal to BCL2 and distal to DCC. Genes Chromosomes Cancer. 1999 Feb; 24(2):156-9.
    View in: PubMed
    Score: 0.002
  84. The t(2;3)(q21;q27) translocation in non-Hodgkin's lymphoma displays BCL6 mutations in the 5' regulatory region and chromosomal breakpoints distant from the gene. Oncogene. 1998 Oct 01; 17(13):1717-22.
    View in: PubMed
    Score: 0.002
  85. Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma. Blood. 1998 Sep 01; 92(5):1743-8.
    View in: PubMed
    Score: 0.002
  86. Nonsyntenic amplification of MYC with CDK4 and MDM2 in a malignant mixed tumor of salivary gland. Cancer Genet Cytogenet. 1998 Sep; 105(2):160-3.
    View in: PubMed
    Score: 0.002
  87. Clinical utility of array comparative genomic hybridization for detection of chromosomal abnormalities in pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008 Aug; 51(2):171-7.
    View in: PubMed
    Score: 0.002
  88. Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma. Mol Cancer Res. 2008 Jun; 6(6):937-46.
    View in: PubMed
    Score: 0.002
  89. Cloning and mapping of human chromosome 6q26-q27 deleted in B-cell non-Hodgkin lymphoma and multiple tumor types. Genomics. 1998 Jun 01; 50(2):170-86.
    View in: PubMed
    Score: 0.002
  90. Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization. Blood. 1998 Apr 15; 91(8):3007-10.
    View in: PubMed
    Score: 0.002
  91. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nat Genet. 1997 Oct; 17(2):226-30.
    View in: PubMed
    Score: 0.002
  92. Assignment of the human B-cell-derived (BCD1) proto-oncogene to 10p14-p15. Genomics. 1997 Aug 01; 43(3):395-7.
    View in: PubMed
    Score: 0.002
  93. BCL8, a novel gene involved in translocations affecting band 15q11-13 in diffuse large-cell lymphoma. Proc Natl Acad Sci U S A. 1997 May 27; 94(11):5728-32.
    View in: PubMed
    Score: 0.002
  94. Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes. Genes Chromosomes Cancer. 2007 Apr; 46(4):373-84.
    View in: PubMed
    Score: 0.002
  95. The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. Blood. 1996 Dec 01; 88(11):4110-7.
    View in: PubMed
    Score: 0.002
  96. Squamous cell carcinoma related oncogene/DCUN1D1 is highly conserved and activated by amplification in squamous cell carcinomas. Cancer Res. 2006 Oct 01; 66(19):9437-44.
    View in: PubMed
    Score: 0.002
  97. Medulloblastoma outcome is adversely associated with overexpression of EEF1D, RPL30, and RPS20 on the long arm of chromosome 8. BMC Cancer. 2006 Sep 12; 6:223.
    View in: PubMed
    Score: 0.002
  98. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood. 1995 Oct 01; 86(7):2708-14.
    View in: PubMed
    Score: 0.002
  99. Cytogenetics of gastric and esophageal adenocarcinomas. 3q deletion as a possible primary chromosomal change. Cancer Genet Cytogenet. 1995 Jun; 81(2):139-43.
    View in: PubMed
    Score: 0.002
  100. Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck. J Clin Oncol. 2004 Oct 01; 22(19):3965-72.
    View in: PubMed
    Score: 0.002
  101. Consistent chromosomal losses in head and neck squamous cell carcinoma cell lines. Genes Chromosomes Cancer. 1994 Sep; 11(1):29-39.
    View in: PubMed
    Score: 0.001
  102. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma. BMC Cancer. 2004 Aug 07; 4:45.
    View in: PubMed
    Score: 0.001
  103. Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker. Cancer Res. 2004 Jun 01; 64(11):3780-9.
    View in: PubMed
    Score: 0.001
  104. Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma. Genes Chromosomes Cancer. 2004 Jan; 39(1):11-21.
    View in: PubMed
    Score: 0.001
  105. Interphase cytogenetics of gastric and esophageal adenocarcinomas. Diagn Mol Pathol. 1993 Dec; 2(4):264-8.
    View in: PubMed
    Score: 0.001
  106. Osteosarcoma in a patient with McCune-Albright syndrome and Mazabraud's syndrome: a case report emphasizing the cytological and cytogenetic findings. Hum Pathol. 2003 Dec; 34(12):1354-7.
    View in: PubMed
    Score: 0.001
  107. Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma. Cancer Res. 1993 Jun 15; 53(12):2732-5.
    View in: PubMed
    Score: 0.001
  108. Genetic analysis identifies putative tumor suppressor sites at 2q35-q36.1 and 2q36.3-q37.1 involved in cervical cancer progression. Oncogene. 2003 May 29; 22(22):3489-99.
    View in: PubMed
    Score: 0.001
  109. Chromosomal aberrations in patients with head and neck squamous cell carcinoma do not vary based on severity of tobacco/alcohol exposure. BMC Genet. 2002 Nov 14; 3:22.
    View in: PubMed
    Score: 0.001
  110. Genome-wide appraisal of thyroid cancer progression. Am J Pathol. 2002 Nov; 161(5):1549-56.
    View in: PubMed
    Score: 0.001
  111. Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas. Am J Pathol. 2002 Aug; 161(2):365-71.
    View in: PubMed
    Score: 0.001
  112. Cytogenetic analysis of a juvenile granulosa cell tumor. Cancer Genet Cytogenet. 1992 Jul 15; 61(2):207-9.
    View in: PubMed
    Score: 0.001
  113. Transformation of human kidney proximal tubule cells by a src-containing retrovirus. Oncogene. 1991 Nov; 6(11):2105-11.
    View in: PubMed
    Score: 0.001
  114. Comparative genomic hybridization and amplotyping by arbitrarily primed PCR in stage A B-CLL. Cancer Genet Cytogenet. 2001 Oct 01; 130(1):8-13.
    View in: PubMed
    Score: 0.001
  115. IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity. 2001 Mar; 14(3):277-89.
    View in: PubMed
    Score: 0.001
  116. Screening for genetic aberrations in papillary thyroid cancer by using comparative genomic hybridization. Surgery. 2000 Dec; 128(6):888-93;discussion 893-4.
    View in: PubMed
    Score: 0.001
  117. Neural differentiation in small round cell tumors of bone and soft tissue with the translocation t(11;22)(q24;q12): an immunohistochemical study of 11 cases. Hum Pathol. 1990 Dec; 21(12):1245-51.
    View in: PubMed
    Score: 0.001
  118. 11p13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinomas. Cancer Res. 1990 Oct 01; 50(19):6410-6.
    View in: PubMed
    Score: 0.001
  119. Deregulation of BCL6 in non-Hodgkin lymphoma by insertion of IGH sequences in complex translocations involving band 3q27. Genes Chromosomes Cancer. 1998 Dec; 23(4):328-36.
    View in: PubMed
    Score: 0.001
  120. Chromosomal amplification is associated with cisplatin resistance of human male germ cell tumors. Cancer Res. 1998 Oct 01; 58(19):4260-3.
    View in: PubMed
    Score: 0.001
  121. Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood. 1998 Jul 01; 92(1):234-40.
    View in: PubMed
    Score: 0.001
  122. Analysis of a 69-kb contiguous genomic sequence at a putative tumor suppressor gene locus on human chromosome 6q27. DNA Seq. 1998; 9(4):189-204.
    View in: PubMed
    Score: 0.001
  123. REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. Blood. 1996 Jan 01; 87(1):25-9.
    View in: PubMed
    Score: 0.001
  124. Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma. Blood. 1992 Oct 01; 80(7):1781-7.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.